drugset / Trial / NCT05590468
A Study to Evaluate Vitamin B3 Derivative to Treat Mitochondrial Myopathy
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the effects of Nicotinamide Riboside (NR) supplement in adult-onset symptoms of mitochondrial myopathy.
Timeline
- Start
- 2023-05-26
- Primary completion
- 2026-11
- Completion
- 2026-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nicotinamide riboside | Small molecule | 500 mg | Oral |